Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The US drug delivery device market will grow moderately through 2027, fueled by growth in patient populations and the approval of biosimilars for drug delivery devices. The opportunities presented in the drug delivery device market will entice drug companies to invest in R&D and to partner with device manufacturing companies to develop patient-centric products.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for drug delivery devices in the US across a 10-year period.
Innovations and product improvements will strongly influence growth in the injection device market.
How will innovative devices, such as needle-free injection systems and smart devices, contribute to the growth of the injection device market?
How will adoption of emerging alternative technologies, such as insulin pumps and closed-loop systems, affect injection device sales?
Companies are increasingly investing in smart drug delivery technologies, which improve patient compliance.
What kind of conditions are these new devices targeting?
How will the launch of new products influence the uptake of drug delivery devices and competitor dynamics?
Already a Client? Log in to access this report.
Sanketh Kamath is an analyst within the Endoscopy and Aesthetics Medtech Insights team at Decision Resources Group, specializing in urology, gynecology, capital equipment, transcatheter embolization and occlusion devices, and medical device outsourcing; he has also worked on standardizing US Procedure Finder codes. Sanketh holds an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, India.